OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

LIPELLA PHARMACEUTICALS INC.

CIK 0001347242Ticker LIPOSEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events62

captured official filings

Registration & offering24

captured official filings

Ownership56

captured official filings

Governance6

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1 filed 2023-11-01 with S-1/A filed 2022-12-15.

Earlier SEC filingLatest SEC filing
345latest comparable sentences
315new-text candidates
225prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • offering51 → 96+45
  • shares182 → 143-39
  • proceeds29 → 14-15
  • management19 → 10-9
  • control15 → 7-8
  • going concern0 → 4+4

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • The Selling Stockholders have represented to the Company that they will consider selling some or all of their respective Stockholder Shares registered pursuant to this registration statement immediately after the pricing of the IPO, as requested by the underwriters for the IPO in order to create an orderly, liquid market for the
  • PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION DATED DECEMBER 15 , 2022 1,166,667 SHARES OF COMMON STOCK This is the initial public offering by Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”, “we”, “us” or “our”).
  • We are registering on the registration statement of which this prospectus forms a part a total of 2,926,624 shares of our common stock, par value $0.0001 per share (“Common Stock”).
Present in earlier filing, not found in latest
  • In addition, pursuant to a certain engagement letter (the “Engagement Letter”) dated October 20, 2023, between the Company and the Placement Agent (as defined below), the Company agreed to issue the Placement Agent or its designees, Placement Agent Warrants to purchase up to 98,684 shares of Common Stock.
  • This prospectus also covers any additional shares of Common Stock that may become issuable upon any adjustment pursuant to the terms of the Warrants issued to the Selling Stockholders by reason of stock splits, stock dividends, and other events described therein.
  • The Warrant Shares will be resold from time to time by the Selling Stockholders listed in the section titled “Selling Stockholders” beginning on page 19.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

DOWNLOAD EDITION

Save a project-ready issuer record.

US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

  • Source-linked filing chronology and registration path
  • Machine-detected amendment and tracked-term change view
  • Official-source index for project-file archiving and downloadable CSV export

Secure checkout by PayPal.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 8-K
    Reporting & material eventsOpen SEC filing →
  2. 8-K
    Reporting & material eventsOpen SEC filing →
  3. 8-K
    Reporting & material eventsOpen SEC filing →
  4. 10-Q
    Reporting & material eventsOpen SEC filing →
  5. 8-K
    Reporting & material eventsOpen SEC filing →
  6. 8-K
    Reporting & material eventsOpen SEC filing →
  7. 8-K
    Reporting & material eventsOpen SEC filing →
  8. 10-Q
    Reporting & material eventsOpen SEC filing →
  9. 8-K
    Reporting & material eventsOpen SEC filing →
  10. 8-K
    Reporting & material eventsOpen SEC filing →
  11. 8-K
    Reporting & material eventsOpen SEC filing →
  12. PRE 14A
    GovernanceOpen SEC filing →
  13. 8-K
    Reporting & material eventsOpen SEC filing →
  14. 8-K
    Reporting & material eventsOpen SEC filing →
  15. 10-Q
    Reporting & material eventsOpen SEC filing →
  16. 8-K
    Reporting & material eventsOpen SEC filing →
  17. 8-K
    Reporting & material eventsOpen SEC filing →
  18. 4
    OwnershipOpen SEC filing →
  19. 8-K
    Reporting & material eventsOpen SEC filing →
  20. 424B5
    Registration & offeringOpen SEC filing →
  21. 424B3
    Registration & offeringOpen SEC filing →
  22. EFFECT
    Registration & offeringOpen SEC filing →
  23. 10-K
    Reporting & material eventsOpen SEC filing →
  24. 8-K
    Reporting & material eventsOpen SEC filing →
  25. 4
    OwnershipOpen SEC filing →
  26. 4
    OwnershipOpen SEC filing →
  27. 8-K
    Reporting & material eventsOpen SEC filing →
  28. 4
    OwnershipOpen SEC filing →
  29. 8-K
    Reporting & material eventsOpen SEC filing →
  30. 8-K
    Reporting & material eventsOpen SEC filing →
  31. 8-K
    Reporting & material eventsOpen SEC filing →
  32. 4
    OwnershipOpen SEC filing →
  33. 424B3
    Registration & offeringOpen SEC filing →
  34. EFFECT
    Registration & offeringOpen SEC filing →
  35. 8-K
    Reporting & material eventsOpen SEC filing →
  36. 8-K
    Reporting & material eventsOpen SEC filing →
  37. 4
    OwnershipOpen SEC filing →
  38. 8-K
    Reporting & material eventsOpen SEC filing →
  39. 4
    OwnershipOpen SEC filing →
  40. 8-K
    Reporting & material eventsOpen SEC filing →
  41. 8-K
    Reporting & material eventsOpen SEC filing →
  42. 8-K
    Reporting & material eventsOpen SEC filing →
  43. 8-K
    Reporting & material eventsOpen SEC filing →
  44. 10-Q
    Reporting & material eventsOpen SEC filing →
  45. SC 13G/A
    OwnershipOpen SEC filing →
  46. SC 13G/A
    OwnershipOpen SEC filing →
  47. DEF 14A
    GovernanceOpen SEC filing →
  48. 8-K
    Reporting & material eventsOpen SEC filing →
  49. PRE 14A
    GovernanceOpen SEC filing →
  50. 8-K
    Reporting & material eventsOpen SEC filing →
  51. 8-K
    Reporting & material eventsOpen SEC filing →
  52. SC 13D/A
    OwnershipOpen SEC filing →
  53. SC 13D/A
    OwnershipOpen SEC filing →
  54. 8-K
    Reporting & material eventsOpen SEC filing →
  55. 8-K
    Reporting & material eventsOpen SEC filing →
  56. SC 13D/A
    OwnershipOpen SEC filing →
  57. 10-Q
    Reporting & material eventsOpen SEC filing →
  58. DEF 14A
    GovernanceOpen SEC filing →
  59. 8-K
    Reporting & material eventsOpen SEC filing →
  60. 8-K
    Reporting & material eventsOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.